Teva reports jump in first-quarter earnings, raises guidance
JERUSALEM (AP) " Israeli generic drug maker Teva Pharmaceutical Industries on Thursday said first-quarter earnings surged over 80 percent and raised its outlook for the rest of the year, citing progress in an aggressive restructuring plan.Teva said it posted net income of $1.06 billion, or $1.03 a share, compared to $580 million, or 57 cents a share, a year earlier. The earnings came despite a 10 percent drop in sales."2018 is off to a solid start," Chief Executive Kare Schultz [...]
EmoticonEmoticon